Showing results (121-130 of 143) with videos related to
Sort By:
Pageof 15
Plos One|January 10, 2014
Histology verification demonstrates that biospectroscopy analysis of cervical cytology identifies underlying disease more accurately than conventional screening: removing the confounder of discordanceKetan Gajjar, Abdullah A Ahmadzai, George Valasoulis, et al.BMC Medicine|July 27, 2023
Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studiesSarah J Bowden, Triada Doulgeraki, Emmanouil Bouras, et al.BMJ (Clinical Research Ed.)|March 1, 2018
Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysisKaroliina Tainio, Antonios Athanasiou, Kari A O Tikkinen, et al.International Journal of Cancer|July 9, 2020
The European response to the WHO call to eliminate cervical cancer as a public health problemMarc Arbyn, Murat Gultekin, Philippe Morice, et al.The Lancet. Oncology|April 1, 2021
Genetic variation in cervical preinvasive and invasive disease: a genome-wide association studySarah J Bowden, Barbara Bodinier, Ilkka Kalliala, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Vulvar inspection at the time of cervical cancer screening: European Society of Gynaecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European Federation for Colposcopy (EFC) consensus statementsMario Preti, Fiona Lewis, Xavier Carcopino, et al.Proceedings of the National Academy of Sciences of the United States of America|March 18, 2020
The intelligent knife (iKnife) and its intraoperative diagnostic advantage for the treatment of cervical diseaseMenelaos Tzafetas, Anita Mitra, Maria Paraskevaidi, et al.Obstetrical & Gynecological Survey|December 30, 2025
Vulvar Inspection at the Time of Cervical Cancer Screening: European Society of Gynecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European Federation for Colposcopy (EFC) Consensus StatementsMario Preti, Fiona Lewis, Xavier Carcopino, et al.Cancer Control : Journal of the Moffitt Cancer Center|April 10, 2025
Implementing High-Risk Human Papillomavirus Self-Sampling for Cervical Cancer Screening in Ghana: A Study (CarciSCAN) ProtocolNadja Taumberger, Ibrahim Friko, Vera Mwinbe-Ere Der, et al.Cancers|February 13, 2026
Human Papillomavirus Testing and Size of CIN3: Implications for the Risk of Microinvasive Cervical CarcinomaMario Preti, Annibale Biggeri, Guglielmo Ronco, et al.Pageof 15